Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 24 entries
Sorted by: Best Match Show Resources per page
First-line antiretroviral therapy for HIV-infected children.

AIDS (London, England)

Terris-Prestholt F.
PMID: 26035324
AIDS. 2015 Jun 19;29(10):1261-2. doi: 10.1097/QAD.0000000000000727.

No abstract available.

Cite
Terris-Prestholt F. First-line antiretroviral therapy for HIV-infected children. AIDS. 2015;29(10):1261-2doi: 10.1097/QAD.0000000000000727.
Terris-Prestholt, F. (2015). First-line antiretroviral therapy for HIV-infected children. AIDS (London, England), 29(10), 1261-2. https://doi.org/10.1097/QAD.0000000000000727
Terris-Prestholt, Fern. "First-line antiretroviral therapy for HIV-infected children." AIDS (London, England) vol. 29,10 (2015): 1261-2. doi: https://doi.org/10.1097/QAD.0000000000000727
Terris-Prestholt F. First-line antiretroviral therapy for HIV-infected children. AIDS. 2015 Jun 19;29(10):1261-2. doi: 10.1097/QAD.0000000000000727. PMID: 26035324.
Copy Download .nbib Format: NLM
Treatment of primary HIV infection.

MedGenMed : Medscape general medicine

Daar ES.
PMID: 12817211
MedGenMed. 2002 Nov 15;4(4):15.

No abstract available.

Cite
Daar ES. Treatment of primary HIV infection. MedGenMed. 2002;4(4):15
Daar, E. S. (2002). Treatment of primary HIV infection. MedGenMed : Medscape general medicine, 4(4), 15.
Daar, Eric S. "Treatment of primary HIV infection." MedGenMed : Medscape general medicine vol. 4,4 (2002): 15.
Daar ES. Treatment of primary HIV infection. MedGenMed. 2002 Nov 15;4(4):15. PMID: 12817211.
Copy Download .nbib Format: NLM
Global AIDS treatment emergency.

Journal of advanced nursing

Rassool GH.
PMID: 14758821
J Adv Nurs. 2004 Jan;45(2):223-4. doi: 10.1111/j.1365-2648.2004.02905.x.

No abstract available.

Cite
Rassool GH. Global AIDS treatment emergency. J Adv Nurs. 2004;45(2):223-4doi: 10.1111/j.1365-2648.2004.02905.x.
Rassool, G. H. (2004). Global AIDS treatment emergency. Journal of advanced nursing, 45(2), 223-4. https://doi.org/10.1111/j.1365-2648.2004.02905.x
Rassool, G Hussein. "Global AIDS treatment emergency." Journal of advanced nursing vol. 45,2 (2004): 223-4. doi: https://doi.org/10.1111/j.1365-2648.2004.02905.x
Rassool GH. Global AIDS treatment emergency. J Adv Nurs. 2004 Jan;45(2):223-4. doi: 10.1111/j.1365-2648.2004.02905.x. PMID: 14758821.
Copy Download .nbib Format: NLM
[Practice of anti-HIV therapy (HAART)].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Shirasaka T.
PMID: 22462132
Nihon Naika Gakkai Zasshi. 2009 Nov 10;98(11):2794-801. doi: 10.2169/naika.98.2794.

No abstract available.

Cite
Shirasaka T. [Practice of anti-HIV therapy (HAART)]. Nihon Naika Gakkai Zasshi. 2009;98(11):2794-801doi: 10.2169/naika.98.2794.
Shirasaka, T. (2009). [Practice of anti-HIV therapy (HAART)]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 98(11), 2794-801. https://doi.org/10.2169/naika.98.2794
Shirasaka, Takuma. "[Practice of anti-HIV therapy (HAART)]." Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine vol. 98,11 (2009): 2794-801. doi: https://doi.org/10.2169/naika.98.2794
Shirasaka T. [Practice of anti-HIV therapy (HAART)]. Nihon Naika Gakkai Zasshi. 2009 Nov 10;98(11):2794-801. doi: 10.2169/naika.98.2794. Japanese. PMID: 22462132.
Copy Download .nbib Format: NLM
Highlights on HIV eradication in 2013.

AIDS (London, England)

Monforte Ad, Svicher V, Nozza S, Lazzarin A, Marchetti G, Perno CF.
PMID: 23939240
AIDS. 2014 Jan 02;28(1):1-7. doi: 10.1097/01.aids.0000433241.78739.79.

No abstract available.

Cite
Monforte Ad, Svicher V, Nozza S, et al. Highlights on HIV eradication in 2013. AIDS. 2014;28(1):1-7doi: 10.1097/01.aids.0000433241.78739.79.
Monforte, A. d., Svicher, V., Nozza, S., Lazzarin, A., Marchetti, G., & Perno, C. F. (2014). Highlights on HIV eradication in 2013. AIDS (London, England), 28(1), 1-7. https://doi.org/10.1097/01.aids.0000433241.78739.79
Monforte, Antonella d'Arminio, et al. "Highlights on HIV eradication in 2013." AIDS (London, England) vol. 28,1 (2014): 1-7. doi: https://doi.org/10.1097/01.aids.0000433241.78739.79
Monforte Ad, Svicher V, Nozza S, Lazzarin A, Marchetti G, Perno CF. Highlights on HIV eradication in 2013. AIDS. 2014 Jan 02;28(1):1-7. doi: 10.1097/01.aids.0000433241.78739.79. PMID: 23939240.
Copy Download .nbib Format: NLM
Economic Impact of HIV in the Highly Active Antiretroviral Therapy Era - Reflections Looking Forward.

AIDS reviews

Oliva-Moreno J, Trapero-Bertran M.
PMID: 30548019
AIDS Rev. 2018;20(4):226-235. doi: 10.24875/AIDSRev.M17000011.

The main data on HIV in high-income countries from the standpoint of health economics are updated and discussed. Specifically, issues surrounding the economic impact of HIV are addressed for health care and occupational perspectives. We review the main epidemiological...

Cite
Oliva-Moreno J, Trapero-Bertran M. Economic Impact of HIV in the Highly Active Antiretroviral Therapy Era - Reflections Looking Forward. AIDS Rev. 2018;20(4):226-235doi: 10.24875/AIDSRev.M17000011.
Oliva-Moreno, J., & Trapero-Bertran, M. (2018). Economic Impact of HIV in the Highly Active Antiretroviral Therapy Era - Reflections Looking Forward. AIDS reviews, 20(4), 226-235. https://doi.org/10.24875/AIDSRev.M17000011
Oliva-Moreno, Juan, and Trapero-Bertran, Marta. "Economic Impact of HIV in the Highly Active Antiretroviral Therapy Era - Reflections Looking Forward." AIDS reviews vol. 20,4 (2018): 226-235. doi: https://doi.org/10.24875/AIDSRev.M17000011
Oliva-Moreno J, Trapero-Bertran M. Economic Impact of HIV in the Highly Active Antiretroviral Therapy Era - Reflections Looking Forward. AIDS Rev. 2018;20(4):226-235. doi: 10.24875/AIDSRev.M17000011. PMID: 30548019.
Copy Download .nbib Format: NLM
Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide.

Infectious disease clinics of North America

Wood BR.
PMID: 31255385
Infect Dis Clin North Am. 2019 Sep;33(3):693-705. doi: 10.1016/j.idc.2019.04.003. Epub 2019 Jun 27.

This review provides a synopsis of key clinical considerations for switching antiretroviral therapy (ART) for individuals with human immunodeficiency virus who have maintained a routinely suppressed viral load. There may be benefits but also risks involved in every ART...

Cite
Wood BR. Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide. Infect Dis Clin North Am. 2019;33(3):693-705doi: 10.1016/j.idc.2019.04.003.
Wood, B. R. (2019). Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide. Infectious disease clinics of North America, 33(3), 693-705. https://doi.org/10.1016/j.idc.2019.04.003
Wood, Brian R. "Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide." Infectious disease clinics of North America vol. 33,3 (2019): 693-705. doi: https://doi.org/10.1016/j.idc.2019.04.003
Wood BR. Switching Antiretroviral Therapy in the Setting of Virologic Suppression: A Why and How-To Guide. Infect Dis Clin North Am. 2019 Sep;33(3):693-705. doi: 10.1016/j.idc.2019.04.003. Epub 2019 Jun 27. PMID: 31255385.
Copy Download .nbib Format: NLM
Preferred antiretroviral drugs for the next decade of scale up.

Journal of the International AIDS Society

Andrieux-Meyer I, Calmy A, Cahn P, Clayden P, Raguin G, Katlama C, Vitoria M, Levin A, Lynch S, Goemaere E, Ford N.
PMID: 23010379
J Int AIDS Soc. 2012 Sep 18;15(2):17986. doi: 10.7448/IAS.15.2.17986.

Global commitments aim to provide antiretroviral therapy (ART) to 15 million people living with HIV by 2015, and recent studies have demonstrated the potential for widespread ART to prevent HIV transmission. Increasingly, countries are adapting their national guidelines to...

Cite
Andrieux-Meyer I, Calmy A, Cahn P, et al. Preferred antiretroviral drugs for the next decade of scale up. J Int AIDS Soc. 2012;15(2):17986doi: 10.7448/IAS.15.2.17986.
Andrieux-Meyer, I., Calmy, A., Cahn, P., Clayden, P., Raguin, G., Katlama, C., Vitoria, M., Levin, A., Lynch, S., Goemaere, E., Ford, N. (2012). Preferred antiretroviral drugs for the next decade of scale up. Journal of the International AIDS Society, 15(2), 17986. https://doi.org/10.7448/IAS.15.2.17986
Andrieux-Meyer, Isabelle, et al. "Preferred antiretroviral drugs for the next decade of scale up." Journal of the International AIDS Society vol. 15,2 (2012): 17986. doi: https://doi.org/10.7448/IAS.15.2.17986
Andrieux-Meyer I, Calmy A, Cahn P, Clayden P, Raguin G, Katlama C, Vitoria M, Levin A, Lynch S, Goemaere E, Ford N. Preferred antiretroviral drugs for the next decade of scale up. J Int AIDS Soc. 2012 Sep 18;15(2):17986. doi: 10.7448/IAS.15.2.17986. PMID: 23010379; PMCID: PMC3494169.
Copy Download .nbib Format: NLM
[No title available]

Journal of preventive medicine and hygiene

Riccardi N, Cenderello G, Croce D, DI Perri G, Rizzardini G, Martini M, DI Biagio A.
PMID: 34622081
J Prev Med Hyg. 2021 Jun 05;62(1):E30-E33. doi: 10.15167/2421-4248/jpmh2021.62.1S3.1892. eCollection 2021 Mar.

No abstract available.

Cite
Riccardi N, Cenderello G, Croce D, et al. Nine ideas to improve the clinical management of HIV infected patients during the COVID-19 pandemic. . J Prev Med Hyg. 2021;62(1):E30-E33doi: 10.15167/2421-4248/jpmh2021.62.1S3.1892.
Riccardi, N., Cenderello, G., Croce, D., DI Perri, G., Rizzardini, G., Martini, M., & DI Biagio, A. (2021). Nine ideas to improve the clinical management of HIV infected patients during the COVID-19 pandemic. . Journal of preventive medicine and hygiene, 62(1), E30-E33. https://doi.org/10.15167/2421-4248/jpmh2021.62.1S3.1892
Riccardi, Niccolò, et al. "Nine ideas to improve the clinical management of HIV infected patients during the COVID-19 pandemic." . Journal of preventive medicine and hygiene vol. 62,1 (2021): E30-E33. doi: https://doi.org/10.15167/2421-4248/jpmh2021.62.1S3.1892
Riccardi N, Cenderello G, Croce D, DI Perri G, Rizzardini G, Martini M, DI Biagio A. Nine ideas to improve the clinical management of HIV infected patients during the COVID-19 pandemic. . J Prev Med Hyg. 2021 Jun 05;62(1):E30-E33. doi: 10.15167/2421-4248/jpmh2021.62.1S3.1892. eCollection 2021 Mar. Italian. PMID: 34622081; PMCID: PMC8452289.
Copy Download .nbib Format: NLM
Combination antiretroviral therapy and cancer risk.

Current opinion in HIV and AIDS

Borges ÁH.
PMID: 27755153
Curr Opin HIV AIDS. 2017 Jan;12(1):12-19. doi: 10.1097/COH.0000000000000334.

PURPOSE OF REVIEW: To review the newest research about the effects of combination antiretroviral therapy (cART) on cancer risk.RECENT FINDINGS: HIV+ persons are at increased risk of cancer. As this risk is higher for malignancies driven by viral and...

Cite
Borges ÁH. Combination antiretroviral therapy and cancer risk. Curr Opin HIV AIDS. 2017;12(1):12-19doi: 10.1097/COH.0000000000000334.
Borges, �. �. H. (2017). Combination antiretroviral therapy and cancer risk. Current opinion in HIV and AIDS, 12(1), 12-19. https://doi.org/10.1097/COH.0000000000000334
Borges, Álvaro H. "Combination antiretroviral therapy and cancer risk." Current opinion in HIV and AIDS vol. 12,1 (2017): 12-19. doi: https://doi.org/10.1097/COH.0000000000000334
Borges ÁH. Combination antiretroviral therapy and cancer risk. Curr Opin HIV AIDS. 2017 Jan;12(1):12-19. doi: 10.1097/COH.0000000000000334. PMID: 27755153; PMCID: PMC5244841.
Copy Download .nbib Format: NLM
Editorial comment: stopping HAART--where we've been, where we are, where we want to be.

The AIDS reader

Valenti WM.
PMID: 15338524
AIDS Read. 2004 Aug;14(8):441.

No abstract available.

Cite
Valenti WM. Editorial comment: stopping HAART--where we've been, where we are, where we want to be. AIDS Read. 2004;14(8):441
Valenti, W. M. (2004). Editorial comment: stopping HAART--where we've been, where we are, where we want to be. The AIDS reader, 14(8), 441.
Valenti, William M. "Editorial comment: stopping HAART--where we've been, where we are, where we want to be." The AIDS reader vol. 14,8 (2004): 441.
Valenti WM. Editorial comment: stopping HAART--where we've been, where we are, where we want to be. AIDS Read. 2004 Aug;14(8):441. PMID: 15338524.
Copy Download .nbib Format: NLM
A public health approach to rapid scale-up of free antiretroviral treatment in China: an ounce of prevention is worth a pound of cure.

Chinese medical journal

Bulterys M, Vermund SH, Chen RY, Ou CY.
PMID: 19567150
Chin Med J (Engl). 2009 Jun 05;122(11):1352-5.

No abstract available.

Cite
Bulterys M, Vermund SH, Chen RY, et al. A public health approach to rapid scale-up of free antiretroviral treatment in China: an ounce of prevention is worth a pound of cure. Chin Med J (Engl). 2009;122(11):1352-5
Bulterys, M., Vermund, S. H., Chen, R. Y., & Ou, C. Y. (2009). A public health approach to rapid scale-up of free antiretroviral treatment in China: an ounce of prevention is worth a pound of cure. Chinese medical journal, 122(11), 1352-5.
Bulterys, Marc, et al. "A public health approach to rapid scale-up of free antiretroviral treatment in China: an ounce of prevention is worth a pound of cure." Chinese medical journal vol. 122,11 (2009): 1352-5.
Bulterys M, Vermund SH, Chen RY, Ou CY. A public health approach to rapid scale-up of free antiretroviral treatment in China: an ounce of prevention is worth a pound of cure. Chin Med J (Engl). 2009 Jun 05;122(11):1352-5. PMID: 19567150.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 24 entries